Eli Lil­ly taps Ama­zon Phar­ma­cy to dis­pense its pre­scrip­tion med­i­cines

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Eli Lil­ly has struck a deal with Ama­zon Phar­ma­cy to de­liv­er its obe­si­ty, di­a­betes and mi­graine med­i­cines di­rect­ly to pa­tients. Ama­zon will work through Lil­ly’s re­cent­ly launched Lil­ly­Di­rect tele­health plat­form.

It’s the first time Ama­zon’s phar­ma­cy busi­ness has worked di­rect­ly with a drug­mak­er, es­tab­lish­ing a new kind of di­rect re­la­tion­ship be­tween the mak­er of a med­ica­tion and the tech and re­tail gi­ant. The new re­la­tion­ship dif­fers from how med­ica­tions are tra­di­tion­al­ly pre­scribed and then dis­pensed through a re­tail phar­ma­cy, po­ten­tial­ly dis­rupt­ing el­e­ments of those busi­ness­es and cre­at­ing a big busi­ness for Ama­zon Phar­ma­cy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER